Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

45

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

45 results for “Arginase”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov36/100

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

ClinicalTrials.gov study NCT02903914. IPD Sharing: NO. Countries: 4. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

ClinicalTrials.gov study NCT03921541. IPD Sharing: Not stated. Countries: 7. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors

ClinicalTrials.gov study NCT03689192. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
dryad36/100

Cell-autonomous and non-cell-autonomous effects of Arginase 2 on cardiac aging

Open the record for dataset details and reuse information.

publicOct 2025View details →
ClinicalTrials.gov32/100

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

ClinicalTrials.gov study NCT02488044. IPD Sharing: Not stated. Countries: 4. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors

ClinicalTrials.gov study NCT02285101. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency

ClinicalTrials.gov study NCT03378531. IPD Sharing: Not stated. Countries: 4. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)

ClinicalTrials.gov study NCT01092091. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)

ClinicalTrials.gov study NCT03455140. IPD Sharing: NO. Countries: 3. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer

ClinicalTrials.gov study NCT02089763. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Arginase Inhibition in Ischemia-reperfusion Injury

ClinicalTrials.gov study NCT02009527. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Pegzilarginase in Subjects <24 Months Old With Arginase 1 Deficiency

ClinicalTrials.gov study NCT06582524. IPD Sharing: NO. Countries: 3. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Effect of L-Citrulline Supplementation on Arginase Activity and Vascular Function in Diabetes

ClinicalTrials.gov study NCT03358264. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
geo24/100

High-throughput screen reveals that atypical antipsychotics promote continual efferocytosis by antagonizing dopamine signaling and promoting vitamin A-dependent Arginase 1 upregulation

GEO Series GSE286555. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenMay 2025View details →
geo24/100

Severe COVID-19 is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells

GEO Series GSE178824. Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJun 2021View details →
geo24/100

Arginase inhibitor reduces fungal dissemination in murine pulmonary cryptococcosis by promoting anti-cryptococcal immunity

GEO Series GSE255160. Mus musculus. 9 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenApr 2024View details →
geo24/100

Arginase 1 deletion in myeloid cells decreases immune suppression and tumor formation in pancreatic cancer

GEO Series GSE203016. Mus musculus. 2 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenFeb 2023View details →
geo24/100

MCTR3 reprograms arthritic monocytes to upregulate Arginase-1 and exert pro-resolving and tissue-protective functions in experimental arthritis

GEO Series GSE174118. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenMar 2022View details →
geo24/100

Loss of CD4+ T cell-intrinsic arginase 1 accelerates Th1 response kinetics and reduces lung pathology during influenza infection

GEO Series GSE214241. Mus musculus. 16 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenAug 2023View details →
geo24/100

Arginase 1 expression by macrophages promotes Cryptococcus neoformans proliferation and invasion into brain microvascular endothelial cells.

GEO Series GSE214001. Mus musculus. 3 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenNov 2022View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record